A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjects

Clinical trial NCT06641388 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06641388
Sponsor: Akeso
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects (HS)

Start date: 2024-11-04
Primary completion: 2025-04-30
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.